Grace Therapeutics, Inc.
USD2.29
-0.01 (-0.22%)
CEO
Prashant Kohli
IPO Date
2012-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.30
Prev. Close
$2.30
Day Low
$2.17
Day High
$2.33
52W Low
$1.79
52W High
$5.18
Market Cap
$0.04B
Volume
0.37M
| -1.6 |
| 31 Mar 2023 | FY | 0.0% | 0.0% | -84.4% | -72.5% | 0.01 | 8.59 | -0.4 |
| 31 Mar 2022 | FY | 0.0% | 0.0% | -11.3% | -9.5% | 0.00 | 13.97 | -1.5 |
| 31 Mar 2021 | FY | 61.2% | -10039.8% | -44.4% | -39.6% | 0.00 | 39.50 | -0.3 |
| 31 Mar 2020 | FY | 0.0% | 0.0% | -277.5% | -157.8% | 0.01 | 2.16 | -0.1 |
| 31 Mar 2019 | FY | 0.0% | 0.0% | -356.4% | -106.7% | 0.12 | 2.05 | -0.1 |
| 31 Mar 2018 | FY | 0.0% | 0.0% | -261.5% | -93.7% | 0.20 | 1.42 | -0.1 |
| 31 Mar 2017 | FY | 0.0% | 0.0% | -48.6% | -41.4% | 0.06 | 4.76 | -0.1 |
| 29 Feb 2016 | FY | -6475.1% | -11892.8% | -23.2% | -22.2% | 0.00 | 9.93 | -0.2 |
| -9.1 |
| 30 Jun 2025 | Q1 | 0.0% | 0.0% | -7.2% | -6.6% | 0.00 | 8.87 | -2.6 |
| 31 Mar 2025 | Q4 | 0.0% | 0.0% | 1.4% | 1.3% | 0.00 | 11.77 | 8.8 |
| 31 Dec 2024 | Q3 | 0.0% | 0.0% | -11.5% | -9.8% | 0.00 | 6.06 | -1.8 |
| 30 Sept 2024 | Q2 | 0.0% | 0.0% | -8.3% | -7.1% | 0.00 | 6.01 | -1.9 |
| 30 Jun 2024 | Q1 | 0.0% | 0.0% | -6.0% | -5.1% | 0.00 | 7.86 | -2.3 |
| 31 Mar 2024 | Q4 | 0.0% | 0.0% | -7.0% | -5.9% | 0.00 | 14.26 | -1.8 |
| 31 Dec 2023 | Q3 | 0.0% | 0.0% | -4.9% | -4.2% | 0.00 | 15.19 | -2.7 |
| 30 Sept 2023 | Q2 | 0.0% | 0.0% | -6.6% | -5.7% | 0.00 | 20.68 | -1.3 |